The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
A Serum Protein Biomarker Panel Improves Outcome Prediction in Human Traumatic Brain Injury
Open accessAbstract
Brain-enriched protein biomarkers of tissue fate are being introduced clinically to aid in traumatic brain injury (TBI) management. The aim of this study was to determine how concentrations of six different protein biomarkers, measured in samples collected during the first weeks after TBI, relate to injury severity and outcome. We included neurocritical care TBI patients that were prospectively enrolled from 2007 to 2013, all having one to three blood samples drawn during the first 2 weeks. The biomarkers analyzed were S100 calcium-binding protein B (S100B), neuron-specific enolase (NSE), glial fibrillary acidic protein (GFAP), ubiquitin carboxy-terminal hydrolase-L1 (UCH-L1), tau, and neurofilament-light (NF-L). Glasgow Outcome Score (GOS) was assessed at 12 months. In total, 172 patients were included. All serum markers were associated with injury severity as classified on computed tomography scans at admission. Almost all biomarkers outperformed other known outcome predictors with higher levels the first 5 days, correlating with unfavorable outcomes, and UCH-L1 (0.260, pseduo- R 2 ) displaying the best discrimination in univariate analyses. After adjusting for acknowledged TBI outcome predictors, GFAP and NF-L added most independent information to predict favorable/unfavorable GOS, improving the model from 0.38 to 0.51 pseudo- R 2 . A correlation matrix indicated substantial covariance, with the strongest correlation between UCH-L1, GFAP, and tau ( r = 0.827–0.880). Additionally, the principal component analysis exhibited clustering of UCH-L1 and tau, as well as GFAP, S100B, and NSE, which was separate from NF-L. In summary, a panel of several different protein biomarkers, all associated with injury severity, with different cellular origin and temporal trajectories, improve outcome prediction models.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ASSESSMENT OF OUTCOME AFTER SEVERE BRAIN DAMAGE A Practical Scale
JENNETT, B. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92830-5 · Cited by 7,501 · cited 1×
“Moderate disability (independent state) and 5 = Recovery (including low grade disability).(39) GOS was assessed prospectively through a quality of life questionnaire, including questions from structured GOS interviews, that was sent to the patient at 12 months following injury, or in case these were not returned, it w…”
Neurofilaments as biomarkers in neurological disorders
Khalil, M., Teunissen, C. E., Otto, M., Piehl, F., Sormani, M. P., Gattringer, T., Barro, C., Kappos, L., Comabella, M., Fazekas, F., et al. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0058-z · Cited by 1,988 · cited 1×
“13 Neurofilament-light (NF-L) is one of the main proteins of the neuroaxonal skeleton and is among the most promising biomarkers for disease severity in multiple sclerosis and amyotrophic lateral sclerosis, 14 as well as in both mild and severe TBI.”
Self-citationThe impact of traumatic brain injuries: A global perspective
Hyder, A. A., Wunderlich, C. A., Puvanachandra, P., Gururaj, G., & Kobusingye, O. C. (2007) · Neurorehabilitation · doi:10.3233/nre-2007-22502 · Cited by 1,816
Pathophysiology of traumatic brain injury
Werner, C., & Engelhard, K. (2007) · British Journal of Anaesthesia · doi:10.1093/bja/aem131 · Cited by 1,712
Clinicopathological evaluation of chronic traumatic encephalopathy in players of American football
Mez, J., Daneshvar, D. H., Kiernan, P. T., Abdolmohammadi, B., Alvarez, V. E., Huber, B. R., Alosco, M. L., Solomon, T. M., Nowinski, C. J., McHale, L., et al. (2017) · JAMA · doi:10.1001/jama.2017.8334 · Cited by 1,098
Kuhle, J., Barro, C., Andreasson, U., Derfuss, T., Lindberg, R., Sandelius, Å., Liman, V., Norgren, N., Blennow, K., & Zetterberg, H. (2016) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2015-1195 · Cited by 740
Self-citationBiomarkers of traumatic injury are transported from brain to blood via the glymphatic system.
Plog, B. A., Dashnaw, M. L., Hitomi, E., Peng, W., Liao, Y., Lou, N., Deane, R., & Nedergaard, M. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.3742-14.2015 · Cited by 525 · cited 1×
“68 It has been speculated that blood–brain barrier (BBB) disruption, 69 glymphatic system activity independent of BBB disruption, 70 or a more-passive release from brain/cerebrospinal flu-id 71 may contribute to efflux.”
Initial CSF total tau correlates with 1-year outcome in patients with traumatic brain injury
Öst, M., Nylén, K., Csajbok, L., Öhrfelt, A. O., Tullberg, M., Wikkelsö, C., Nellgård, P., Rosengren, L., Blennow, K., & Nellgård, B. (2006) · Neurology · doi:10.1212/01.wnl.0000242732.06714.0f · Cited by 321
Self-citationRandall, J., Mörtberg, E., Provuncher, G. K., Fournier, D. R., Duffy, D. C., Rubertsson, S., Blennow, K., Zetterberg, H., & Wilson, D. H. (2013) · Resuscitation · doi:10.1016/j.resuscitation.2012.07.027 · Cited by 230 · cited 2×
“15 Although previous reports found that UCH-L1 (10h), tau (10h), and S100B (24h) have shorter effective half-lives in serum as compared to GFAP (48h), NSE (48h), and NF-L ( > 1 weeks) in patients with severe TBI, 25,26 this is not entirely evident in the current data set.”
Self-citationTakala, R. S. K., Posti, J. P., Runtti, H., Newcombe, V. F., Outtrim, J., Katila, A. J., Frantzén, J., Ala-Seppälä, H., Kyllönen, A., Maanpää, H.-R., et al. (2016) · World Neurosurgery · doi:10.1016/j.wneu.2015.10.066 · Cited by 105
Cited by
Neurofilaments as biomarkers in neurological disorders — towards clinical application
Khalil, M., Teunissen, C. E., Lehmann, S., Otto, M., Piehl, F., Ziemssen, T., Bittner, S., Sormani, M. P., Gattringer, T., Abu-Rumeileh, S., et al. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-00955-x · Cited by 446
Self-citationCzeiter, E., Amrein, K., Gravesteijn, B. Y., Lecky, F., Menon, D. K., Mondello, S., Newcombe, V. F. J., Richter, S., Steyerberg, E. W., Vyvere, T. V., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102785 · Cited by 280
Huebschmann, N. A., Luoto, T. M., Karr, J. E., Berghem, K., Blennow, K., Zetterberg, H., Ashton, N. J., Simrén, J., Posti, J. P., Gill, J. M., et al. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.01054 · Cited by 85
Self-citationPybus, A. F., Bitarafan, S., Brothers, R. O., Rohrer, A., Khaitan, A., Moctezuma, F. R., Udeshi, K., Davies, B., Triplett, S., Griffin, M. N., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03128-1 · Cited by 12
Begenisic, T., Pavese, C., Aiachini, B., Nardone, A., & Rossi, D. (2021) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-211169 · Cited by 7
Metadata
- Authors
- Thelin, E., Al Nimer, F., Frostell, A., Zetterberg, H., Blennow, K., Nyström, H., Svensson, M., Bellander, B.-M., Piehl, F., & Nelson, D. W.
- Venue
- Journal of Neurotrauma
- Publisher
- SAGE Publications
- Published
- 2019-10-15
- Volume
- 36
- Issue
- 20
- Pages
- 2850-2862
- ISSN
- 0897-7151 (ISSN-L)
- 1557-9042
- OpenAlex
- W2944160948
- Cited by
- 176
- References
- 10
- FWCI
- 14.43
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.